{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:58:38Z","timestamp":1793336318944,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-023-04051-4","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T10:01:57Z","timestamp":1697191317000},"page":"60-68","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Interobserver agreement and prognostic value of image-based scoring systems in patients with primary sclerosing cholangitis"],"prefix":"10.1007","volume":"49","author":[{"given":"Erick Cruz","family":"Grave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Loehfelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Corwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Zepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harjot K.","family":"Bath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Dhaliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Yazdanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3906-6811","authenticated-orcid":false,"given":"Christopher L.","family":"Bowlus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"key":"4051_CR1","doi-asserted-by":"crossref","unstructured":"Bowlus, C.L., et al., AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology, 2022.","DOI":"10.1002\/hep.32771"},{"issue":"8","key":"4051_CR2","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.cgh.2021.08.039","volume":"20","author":"PJ Trivedi","year":"2022","unstructured":"Trivedi, P.J., et al., Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies. Clin Gastroenterol Hepatol, 2022. 20(8): p. 1687\u20131700 e4.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"4051_CR3","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1053\/j.gastro.2021.07.046","volume":"161","author":"CY Ponsioen","year":"2021","unstructured":"Ponsioen, C.Y., et al., Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process. Gastroenterology, 2021. 161(6): p. 1764-1775.","journal-title":"Gastroenterology"},{"issue":"7","key":"4051_CR4","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0025-6196(11)64614-4","volume":"75","author":"WR Kim","year":"2000","unstructured":"Kim, W.R., et al., A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc, 2000. 75(7): p. 688-94.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"4051_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/hep.30085","volume":"71","author":"JE Eaton","year":"2020","unstructured":"Eaton, J.E., et al., Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes of the Disease: A Derivation and Validation Study Using Machine Learning. Hepatology, 2020. 71(1): p. 214-224.","journal-title":"Hepatology"},{"issue":"10","key":"4051_CR6","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1136\/gutjnl-2016-313681","volume":"67","author":"EM de Vries","year":"2018","unstructured":"de Vries, E.M., et al., A novel prognostic model for transplant-free survival in primary sclerosing cholangitis. Gut, 2018. 67(10): p. 1864-1869.","journal-title":"Gut"},{"issue":"3","key":"4051_CR7","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/hep.28963","volume":"65","author":"EM de Vries","year":"2017","unstructured":"de Vries, E.M., et al., Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study. Hepatology, 2017. 65(3): p. 907-919.","journal-title":"Hepatology"},{"issue":"4","key":"4051_CR8","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1053\/j.gastro.2013.12.030","volume":"146","author":"C Corpechot","year":"2014","unstructured":"Corpechot, C., et al., Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis. Gastroenterology, 2014. 146(4): p. 970-9; quiz e15-6.","journal-title":"Gastroenterology"},{"issue":"10","key":"4051_CR9","doi-asserted-by":"publisher","first-page":"e0164224","DOI":"10.1371\/journal.pone.0164224","volume":"11","author":"H Ehlken","year":"2016","unstructured":"Ehlken, H., et al., Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis. PLoS One, 2016. 11(10): p. e0164224.","journal-title":"PLoS One"},{"issue":"7","key":"4051_CR10","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.cgh.2019.10.041","volume":"18","author":"JE Eaton","year":"2020","unstructured":"Eaton, J.E., et al., Changes in Liver Stiffness, Measured by Magnetic Resonance Elastography, Associated With Hepatic Decompensation in Patients With Primary Sclerosing Cholangitis. Clin Gastroenterol Hepatol, 2020. 18(7): p. 1576-1583 e1.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"4051_CR11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/hep.26620","volume":"59","author":"A Ruiz","year":"2014","unstructured":"Ruiz, A., et al., Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression. Hepatology, 2014. 59(1): p. 242-50.","journal-title":"Hepatology"},{"issue":"11","key":"4051_CR12","doi-asserted-by":"publisher","first-page":"100577","DOI":"10.1016\/j.jhepr.2022.100577","volume":"4","author":"N Cazzagon","year":"2022","unstructured":"Cazzagon, N., et al., Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis. JHEP Rep, 2022. 4(11): p. 100577.","journal-title":"JHEP Rep"},{"key":"4051_CR13","doi-asserted-by":"crossref","unstructured":"Cristoferi, L., et al., A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis. Dig Liver Dis, 2022.","DOI":"10.1016\/j.dld.2022.08.010"},{"issue":"1","key":"4051_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00330-021-08142-y","volume":"32","author":"MF Ismail","year":"2022","unstructured":"Ismail, M.F., et al., Evaluation of quantitative MRCP (MRCP+) for risk stratification of primary sclerosing cholangitis: comparison with morphological MRCP, MR elastography, and biochemical risk scores. Eur Radiol, 2022. 32(1): p. 67-77.","journal-title":"Eur Radiol"},{"issue":"9","key":"4051_CR15","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1055\/s-0030-1255527","volume":"42","author":"CY Ponsioen","year":"2010","unstructured":"Ponsioen, C.Y., et al., Validation of a cholangiographic prognostic model in primary sclerosing cholangitis. Endoscopy, 2010. 42(9): p. 742-7.","journal-title":"Endoscopy"},{"issue":"12","key":"4051_CR16","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1111\/liv.13899","volume":"38","author":"A Tenca","year":"2018","unstructured":"Tenca, A., et al., The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis. Liver Int, 2018. 38(12): p. 2329-2339.","journal-title":"Liver Int"},{"issue":"13","key":"4051_CR17","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1016\/j.cgh.2019.03.013","volume":"17","author":"S Lemoinne","year":"2019","unstructured":"Lemoinne, S., et al., Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis. Clin Gastroenterol Hepatol, 2019. 17(13): p. 2785-2792.e3.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4051_CR18","doi-asserted-by":"publisher","first-page":"109884","DOI":"10.1016\/j.ejrad.2021.109884","volume":"142","author":"A Grigoriadis","year":"2021","unstructured":"Grigoriadis, A., et al., Assessment of prognostic value and interreader agreement of ANALI scores in patients with primary sclerosing cholangitis. Eur J Radiol, 2021. 142: p. 109884.","journal-title":"Eur J Radiol"},{"issue":"2","key":"4051_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/00365521.2020.1720281","volume":"55","author":"A Grigoriadis","year":"2020","unstructured":"Grigoriadis, A., et al., Inter-reader agreement of interpretation of radiological course of bile duct changes between serial follow-up magnetic resonance imaging\/3D magnetic resonance cholangiopancreatography of patients with primary sclerosing cholangitis. Scand J Gastroenterol, 2020. 55(2): p. 228-235.","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"4051_CR20","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/hep4.1860","volume":"6","author":"EA Selvaraj","year":"2022","unstructured":"Selvaraj, E.A., et al., A Quantitative Magnetic Resonance Cholangiopancreatography Metric of Intrahepatic Biliary Dilatation Severity Detects High-Risk Primary Sclerosing Cholangitis. Hepatol Commun, 2022. 6(4): p. 795-808.","journal-title":"Hepatol Commun"},{"issue":"3","key":"4051_CR21","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1148\/radiol.2243011495","volume":"224","author":"H Awaya","year":"2002","unstructured":"Awaya, H., et al., Cirrhosis: modified caudate-right lobe ratio. Radiology, 2002. 224(3): p. 769-74.","journal-title":"Radiology"},{"issue":"2","key":"4051_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/apt.14797","volume":"48","author":"R Zenouzi","year":"2018","unstructured":"Zenouzi, R., et al., Follow-up magnetic resonance imaging\/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret. Aliment Pharmacol Ther, 2018. 48(2): p. 169-178.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-04051-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-023-04051-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-023-04051-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T02:04:09Z","timestamp":1705370649000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-023-04051-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["4051"],"URL":"https:\/\/doi.org\/10.1007\/s00261-023-04051-4","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]},"assertion":[{"value":"6 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CLB has received grants from Boston Scientific, Calliditas Therapeutics, Cara Therapeutics, ChemoMab, COUR Pharmaceuticals, Cymabay Therapeutics, Gilead Sciences, GSK Pharmaceuticals, Hanmi Pharmaceuticals, Intercept Pharmaceuticals, Ipsen Bioscience, Mirum Pharmaceuticals, Novo Nordisk, Pliant Therapeutics, and Viking Therapeutics. CLB has been an advisor for Cymabay Therapeutics, GSK Pharmaceuticals, Invea Therapeutics, and Ipsen Bioscience. MTC is a consultant for Corcept Therapeutics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}